Home » Press and MediaPage 9

In the news

October 29, 2020

Testing drugs within a tumor may combat pancreatic cancer drug resistance, ‘time machine’ suggests

Bumsoo Han, a professor of mechanical engineering, developed a tool that is helping scientists to more efficiently discover and test new drugs for pancreatic cancer.

October 22, 2020

Technology shines the light on ovarian cancer treatments

A Purdue University scientist is working to use simple LED light to help determine if certain chemotherapy options will work for specific patients.

October 8, 2020

Walther Cancer Foundation $11 million investment to expand IU-Purdue bioinformatics collaboration

The Walther Cancer Foundation will invest $11 million to advance collaborative cancer research at Indiana University and Purdue University by supporting scientists through bioinformatics — an increasingly critical aspect of their work.

October 6, 2020

Novel testing platform designed for breast cancer cells

A Purdue University team has developed a novel testing platform to evaluate how breast cancer cells respond to the recurrent stretching that occurs in the lungs during breathing.

August 10, 2020

Purdue scientist identifies new target for wide array of cancers

Purdue University’s Zhong-Yin Zhang’s team has discovered a novel “phosphatase cascade” that plays a critical role in pancreas, liver, kidney, lung, breast, prostate, brain and other types of cancers.

New treatment approach uses killer cells to treat deadly brain tumors

A Purdue University cancer innovator and his team have developed a promising new approach to treating these tumors using a type of immune cell called the natural killer (NK) cell.

Chemistry innovator widening, quickening uses of spectrometry

The clock is ticking when a neurosurgeon is trying to remove a brain tumor but also determining its malignancy and type. Instead of sending samples to a lab where the necessary testing equipment resides to answer those questions, a Purdue scientist is working on shrinking that equipment for use in the surgical room.

$2 million SBIR grant fast-tracks cancer drug platform technology, which aims to better treat relapse

A $1,999,998 SBIR Phase I/II grant from the National Cancer Institute to KinaRx LLC, a Purdue University-affiliated startup, will help fast-track to human trials a novel platform aimed at treating relapse for AML and other diseases.

February 26, 2020

Stretchable, wearable coils may make MRI, other medical tests easier on patients

Anyone who has had a mammogram or an MRI knows how uncomfortable and awkward the tests can be. Now, Purdue University researchers have taken technology used in the defense and aerospace industries to create a novel way of doing some medical imaging.

February 13, 2020

Pancreatic cancer ‘time machine’ exposes plot twist in cell growth and invasion

Invasive cancer sprouts from an artificial pancreatic duct engineered by Purdue University researchers. The cell bodies are stained magenta and the nuclei are stained blue.